ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. A multi-center cohort study evaluated he…

A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy

Kidney International·August 21Open Access
Urology & NephrologyPractice changingIgA NephropathyMulticenter Retrospective Cohort StudyUrinalysis / Biomarker AssessmentAdult

Summary

View source

What was studied

This multicenter retrospective cohort study (July 2015–July 2025) evaluated whether dipstick hemoglobinuria and microscopic hematuria are associated with active histologic lesions on Oxford Classification (MEST-C) in 441 adults with biopsy-proven IgA nephropathy (IgAN), compared to proteinuria as the current standard marker.

Key findings

Hemoglobinuria showed the strongest association with composite active lesions (M1, E1, and/or C1/C2): pooled OR 2.28 (95% CI 1.76–2.97), outperforming hematuria (OR 1.36, 1.22–1.51) and proteinuria (OR 1.20, 1.04–1.38). Hemoglobinuria and hematuria were not associated with chronic lesions (T1/T2), while proteinuria was (OR 1.35, 1.20–1.52).

Study limitations

- Retrospective design with potential selection bias (only biopsied patients included). - Urinalysis was concurrent with biopsy but dipstick hemoglobinuria may not reflect sustained disease activity over time. - Individual center-level confounders may persist despite random-effects pooling.

Clinical implications

Add dipstick hemoglobinuria to routine IgAN assessment — it flags active glomerular inflammation (endocapillary, mesangial, crescentic lesions) better than proteinuria alone. Persistent or worsening hemoglobinuria on dipstick may warrant closer monitoring or earlier biopsy review for active disease.

Related Questions

Explore related topics

How does hemoglobinuria compare to proteinuria for monitoring disease activity in IgA nephropathy?What do Oxford Classification MEST-C scores tell us about IgAN prognosis and treatment decisions?Should dipstick findings change how we follow IgAN patients between biopsies?

Publication Details

Year
2026
Journal
Kidney International
Sample Size
n=441
Source
View article
Keep scrolling
More content below.
Up Next